Anthem BioSciences Ltd. engages in contract research, development and manufacturing, and organization with fully integrated operations spanning across drug discovery, development and manufacturing. It operates through the CRDMO Services and Specialty Ingredients segments. The CRDMO Services segment deals with drug research and development. The Specialty Ingredients segment sell complex specialized fermentation-based APIs, including probiotics, enzymes, peptides, nutritional actives, vitamin analogues and biosimilars. The company was founded by Ajay Bhardwaj, Ganesh Sambasivam, and K Ravindra Chandrappa on June 13, 2006 and is headquartered in Bangalore, India.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
N/A
Frequently Asked Questions
What is Market Cap of Anthem Biosciences Ltd.?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Anthem Biosciences Ltd. market cap is 466.02B.
What is the 52-week high for Anthem Biosciences Ltd.?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Anthem Biosciences Ltd. 52 week high is 864.90 as of September 07, 2025.
What is the 52-week low for Anthem Biosciences Ltd.?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Anthem Biosciences Ltd. 52 week low is 701.90 as of September 07, 2025.
What is Anthem Biosciences Ltd. stock price today?
Anthem Biosciences Ltd. stock price today is 828.95.
What was Anthem Biosciences Ltd. stock price yesterday?
Anthem Biosciences Ltd. stock price yesterday was 844.00.
What is the 50-day moving average of Anthem Biosciences Ltd.?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Anthem Biosciences Ltd. 50-day moving average is 783.96.